Article Text

Download PDFPDF
Analysis of clinical enquiries received by five COVID-19 vaccination centres in the UK
  1. Sukhpreet Bassi,
  2. Rubena Begum,
  3. Raliat Onatade,
  4. Catherine Olie
  1. Pharmacy, Barts Health NHS Trust, London, UK
  1. Correspondence to Sukhpreet Bassi, Pharmacy, Barts Health NHS Trust, London E1 1FR, UK; sukhpreet.bassi{at}


The aim of this study was to explore the nature of clinical enquiries received by UK vaccination centres during the early stages in the roll-out of the COVID-19 vaccination programme. Four centres were situated in acute hospitals and one centre was in a designated public site. Data were collected for eight consecutive weeks between January and February 2021. The hospital centres administered a total of 28 995 doses of the Pfizer BioNTech vaccine, receiving 806 enquiries (1 enquiry per 36 vaccinations, 2.7%). The public centre administered 29 167 doses of AstraZeneca vaccine, receiving 439 enquiries (1 enquiry per 66 vaccinations, 1.5%). Combined enquiry rate was 2.1%. The most common enquiries were related to allergies (44%), compatibility with other medicine (22%) and immunosuppression (16%). These were the topics of clinical guidance that were subject to regular change. Public health programmes implementing novel therapies should ensure the provision of sufficient enquiry answering capacity.

  • COVID-19
  • clinical medicine
  • education, pharmacy
  • education, pharmacy, continuing
  • medical informatics
  • pharmacy service, hospital
  • quality of health care
  • public health

Data availability statement

No data are available. Not applicable.

This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.